From: Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
Therapy modality | Chemotherapeutic agents | Adjuvant components | Working mechanism | Refs | ||
---|---|---|---|---|---|---|
Single Chemotherapy | BTZ; DOX; CPT | PVCL-GMA NGs; RGD peptide; CaO2/MnO2; | Enhancing enrichment and penestration of drug in tumor | |||
Chemotherapy-CDT | DSF; DOX | PVP/Cu-HMSNs; ZIF-8 | The nontoxicity-to-toxicity transition of DSF and H2O2-responsive·OH generation | |||
Chemotherapy-PTT | DSF; AQ4N | PVP/Cu-HMPBs; CuS Silicene@Silica | PTT-enhanced the release of chemotherapeutic agents and anti-cancer activity | |||
Chemotherapy-PDT | Cabazitaxel; DOX | Ce6; TPABTDCT | PDT-activated the anti-cancer activity of prodrugs | |||
Chemotherapy-Starvation therapy | TPZ; AQ4N; DOX | Gox; 2DG | Starvation-sensitized tumor cells to chemo-drugs | |||
Chemotherapy- Immunotherapy | DOX | NLG919; IMDQ | Chemotherapy-induced robust tumoral ICD to activate anti-cancer immunity |